Visfatin causes endothelium-dependent relaxation in isolated blood vessels

Biochemical and Biophysical Research Communications

Volumn 383, Issue 4, 2009, Pages 503-508

  Yamawaki, Hideyuki ^a   Hara, Naoko ^a   Okada, Muneyoshi ^a   Hara, Yukio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Adipokine; Contraction; Endothelium; Nitric oxide; Signal transduction

Indexed keywords

ACETYLCHOLINE; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NORADRENALIN; PROTEIN KINASE B; SERINE;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION; WESTERN BLOTTING;

ANIMALS; AORTA; BENZOXAZOLES; CAROTID ARTERIES; CELL ADHESION MOLECULES; CHALCONE; ENDOTHELIUM, VASCULAR; HUMANS; MALE; MICROFILAMENT PROTEINS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTOR, INSULIN; RECOMBINANT PROTEINS; VASODILATION;

RATTUS;

EID: 65449181941     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.074     Document Type: Article

References (32)

1. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., and Shimomura I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307 (2005) 426-430
2. Berndt J., Kloting N., Kralisch S., Kovacs P., Fasshauer M., Schon M.R., Stumvoll M., and Bluher M. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54 (2005) 2911-2916
3. Choi K.M., Kim J.H., Cho G.J., Baik S.H., Park H.S., and Kim S.M. Effect of exercise training on plasma visfatin and eotaxin levels. Eur. J. Endocrinol. 157 (2007) 437-442
4. Chen M.P., Chung F.M., Chang D.M., Tsai J.C., Huang H.F., Shin S.J., and Lee Y.J. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 91 (2006) 295-299
5. Lopez-Bermejo A., Chico-Julia B., Fernandez-Balsells M., Recasens M., Esteve E., Casamitjana R., Ricart W., and Fernandez-Real J.M. Serum visfatin increases with progressive beta-cell deterioration. Diabetes 55 (2006) 2871-2875
6. Pagano C., Pilon C., Olivieri M., Mason P., Fabris R., Serra R., Milan G., Rossato M., Federspil G., and Vettor R. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J. Clin. Endocrinol. Metab. 91 (2006) 3165-3170
7. Revollo J.R., Korner A., Mills K.F., Satoh A., Wang T., Garten A., Dasgupta B., Sasaki Y., Wolberger C., Townsend R.R., Milbrandt J., Kiess W., and Imai S. Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6 (2007) 363-375
8. Wang P., Xu T.Y., Guan Y.F., Su D.F., Fan G.R., and Miao C.Y. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc. Res. 81 (2009) 370-380
9. Samal B., Sun Y., Stearns G., Xie C., Suggs S., and McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol. Cell. Biol. 14 (1994) 1431-1437
10. Moschen A.R., Kaser A., Enrich B., Mosheimer B., Theurl M., Niederegger H., and Tilg H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J. Immunol. 178 (2007) 1748-1758
11. Adya R., Tan B.K., Punn A., Chen J., and Randeva H.S. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovasc. Res. 78 (2008) 356-365
12. Kim S.R., Bae Y.H., Bae S.K., Choi K.S., Yoon K.H., Koo T.H., Jang H.O., Yun I., Kim K.W., Kwon Y.G., Yoo M.A., and Bae M.K. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim. Biophys. Acta 1783 (2008) 886-895
13. Xi W., Satoh H., Kase H., Suzuki K., and Hattori Y. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Biochem. Biophys. Res. Commun. 332 (2005) 200-205
14. Cheng K.K., Lam K.S., Wang Y., Huang Y., Carling D., Wu D., Wong C., and Xu A. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 56 (2007) 1387-1394
15. Gentile M.T., Vecchione C., Marino G., Aretini A., Di Pardo A., Antenucci G., Maffei A., Cifelli G., Iorio L., Landolfi A., Frati G., and Lembo G. Resistin impairs insulin-evoked vasodilation. Diabetes 57 (2008) 577-583
16. Kimura K., Tsuda K., Baba A., Kawabe T., Boh-oka S., Ibata M., Moriwaki C., Hano T., and Nishio I. Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem. Biophys. Res. Commun. 273 (2000) 745-749
17. Fortuno A., Rodriguez A., Gomez-Ambrosi J., Muniz P., Salvador J., Diez J., and Fruhbeck G. Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology 143 (2002) 3555-3560
18. Mukohda M., Yamawaki H., Nomura H., Okada M., and Hara Y. Methylglyoxal inhibits smooth muscle contraction in isolated blood vessels. J. Pharmacol. Sci. 109 (2009) 305-310
19. Nomura H., Yamawaki H., Mukohda M., Okada M., and Hara Y. Mechanisms underlying pioglitazone-mediated relaxation in isolated blood vessel. J. Pharmacol. Sci. 108 (2008) 258-265
20. Yamawaki H., Pan S., Lee R.T., and Berk B.C. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J. Clin. Invest. 115 (2005) 733-738
21. Yamawaki H., Saito K., Okada M., and Hara Y. Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells. Am. J. Physiol. Cell Physiol. 295 (2008) C1510-C1517
22. Blum G., Gazit A., and Levitzki A. Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics. J. Biol. Chem. 278 (2003) 40442-40454
23. Harris M.B., Ju H., Venema V.J., Liang H., Zou R., Michell B.J., Chen Z.P., Kemp B.E., and Venema R.C. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J. Biol. Chem. 276 (2001) 16587-16591
24. Thomas S.R., Chen K., and Keaney Jr. J.F. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J. Biol. Chem. 277 (2002) 6017-6024
25. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., and Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 (1999) 597-601
26. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., and Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 (1999) 601-605
27. Smolenski A., Bachmann C., Reinhard K., Honig-Liedl P., Jarchau T., Hoschuetzky H., and Walter U. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J. Biol. Chem. 273 (1998) 20029-20035
28. Lohn M., Dubrovska G., Lauterbach B., Luft F.C., Gollasch M., and Sharma A.M. Periadventitial fat releases a vascular relaxing factor. FASEB J. 16 (2002) 1057-1063
29. Verlohren S., Dubrovska G., Tsang S.Y., Essin K., Luft F.C., Huang Y., and Gollasch M. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 44 (2004) 271-276
30. Gollasch M., and Dubrovska G. Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. Trends Pharmacol. Sci. 25 (2004) 647-653
31. Garg U.C., and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83 (1989) 1774-1777
32. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142